GB0809360D0 - Calcium modulation - Google Patents
Calcium modulationInfo
- Publication number
- GB0809360D0 GB0809360D0 GBGB0809360.1A GB0809360A GB0809360D0 GB 0809360 D0 GB0809360 D0 GB 0809360D0 GB 0809360 A GB0809360 A GB 0809360A GB 0809360 D0 GB0809360 D0 GB 0809360D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- calcium modulation
- modulation
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0809360.1A GB0809360D0 (en) | 2008-05-22 | 2008-05-22 | Calcium modulation |
PCT/GB2009/001295 WO2009141627A1 (en) | 2008-05-22 | 2009-05-22 | Treating niemann-pick disease type c and related disorders by elevating intracellular calcium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0809360.1A GB0809360D0 (en) | 2008-05-22 | 2008-05-22 | Calcium modulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0809360D0 true GB0809360D0 (en) | 2008-07-02 |
Family
ID=39615951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0809360.1A Ceased GB0809360D0 (en) | 2008-05-22 | 2008-05-22 | Calcium modulation |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0809360D0 (en) |
WO (1) | WO2009141627A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR122019024895B8 (en) * | 2008-06-26 | 2021-07-27 | Orphazyme As | use of a bioactive agent capable of increasing the intracellular concentration of hsp70 |
AU2011335545A1 (en) | 2010-11-30 | 2013-06-13 | Orphazyme Aps | Methods for increasing intracellular activity of Hsp70 |
EP2758403B1 (en) | 2011-09-21 | 2016-04-27 | Inception Orion, Inc. | Tricyclic compounds useful as neurogenic and neuroprotective agents |
CN104812737A (en) * | 2012-05-08 | 2015-07-29 | 塞利克斯比奥私人有限公司 | Compositions and methods for treatment of hyperglycemia |
EP2906570A4 (en) * | 2012-10-15 | 2016-06-08 | Yeda Res & Dev | Use of sphingoid long chain bases and their analogs in treating and preventing bacterial infections |
EP2968300A4 (en) * | 2013-03-15 | 2016-09-28 | Unither Virology Llc | Antibacterial compounds |
MX2015016771A (en) | 2013-06-25 | 2016-03-31 | Squibb Bristol Myers Co | Carbazole carboxamide compounds useful as kinase inhibitors. |
TWI648272B (en) | 2013-06-25 | 2019-01-21 | 美商必治妥美雅史谷比公司 | Substituted tetrahydrocarbazole and carbazole carbamide compounds |
BR112017004948A2 (en) | 2014-09-15 | 2017-12-05 | Orphazyme Aps | pharmaceutical formulation. |
BR112017007563A2 (en) | 2014-10-24 | 2017-12-19 | Bristol Myers Squibb Co | tricyclic atropisomers compounds |
SG10201903578VA (en) | 2014-10-24 | 2019-05-30 | Bristol Myers Squibb Co | Indole carboxamides compounds useful as kinase inhibitors |
EA032361B1 (en) | 2014-10-24 | 2019-05-31 | Бристол-Майерс Сквибб Компани | Tricyclic compounds |
WO2016110702A1 (en) * | 2015-01-07 | 2016-07-14 | Isis Innovation Limited | Treatment of mycobacterial infection |
WO2016210116A1 (en) * | 2015-06-25 | 2016-12-29 | Lysosomal Therapeutics Inc. | Methods and compositions for treating lysosomal storage disorders |
WO2016210120A1 (en) * | 2015-06-25 | 2016-12-29 | Lysosomal Therapeutics Inc. | Methods and compositions for treating neurodegenerative disorders |
US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
US20190111041A1 (en) | 2016-04-29 | 2019-04-18 | Orphazyme A/S | Arimoclomol for treating glucocerebrosidase associated disorders |
EP3323415A1 (en) * | 2016-11-16 | 2018-05-23 | Institut du Cerveau et de la Moelle Epiniere-ICM | Treatment of neurodegenerative diseases |
IL260690A (en) | 2018-07-19 | 2018-12-31 | Yeda Res & Dev | Sphingosine analogs and use thereof against bacterial lung infections |
EP3952859A4 (en) * | 2019-04-12 | 2023-05-10 | Loma Linda University | Methods for treatment of niemann-pick disease type c |
KR20230128462A (en) | 2020-11-19 | 2023-09-05 | 제브라 덴마크 에이/에스 | Process for preparing arimoclomol citrate and intermediates thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1126832A2 (en) * | 1998-10-27 | 2001-08-29 | Yale University | Conductance of improperly folded proteins through the secretory pathway |
US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
-
2008
- 2008-05-22 GB GBGB0809360.1A patent/GB0809360D0/en not_active Ceased
-
2009
- 2009-05-22 WO PCT/GB2009/001295 patent/WO2009141627A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009141627A1 (en) | 2009-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0809360D0 (en) | Calcium modulation | |
TWI316121B (en) | Lamp | |
TWI349087B (en) | Lamp | |
TWI367207B (en) | Substituted pyrrolidine-2-carboxamides | |
EG26153A (en) | Absorbents | |
AU324520S (en) | Shoes | |
AU322403S (en) | Lamp | |
GB0904436D0 (en) | Engagement arrangement | |
TWI349085B (en) | Lamp | |
EP2192916A4 (en) | Modulation of synaptogenesis | |
GB0801032D0 (en) | Immune modulation | |
IL208281A0 (en) | Substituted cyclohexyldiamines | |
IL209175A0 (en) | Substituted qunazolines | |
GB0806046D0 (en) | Lamp | |
GB0808886D0 (en) | Dual purpose modulator | |
GB2460543B (en) | Flange spreader | |
IL190168A0 (en) | Orthopedic shoe | |
SI2180242T1 (en) | Lamp | |
GB0810084D0 (en) | Eqne trainign aid | |
GB2457967B (en) | Modulation scheme | |
GB0806468D0 (en) | Mind plan | |
GB0811938D0 (en) | Pintagram or Drinkagram | |
GB0804677D0 (en) | Shoe | |
AU324522S (en) | Shoes | |
AU319955S (en) | Lamp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |